Coivas Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.7/10
Best for: all-inclusive compounded GLP-1 at one flat price per dose, with a conditional money-back guarantee
Coivas scores highest on trust and safety in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Coivas is an all-inclusive compounded GLP-1 telehealth service operated by WellVi LLC, with care from independent clinicians through Beluga Health. Compounded semaglutide is $249/mo month-to-month ($178/mo on the quarterly plan) and tirzepatide is $299/mo ($254/mo quarterly), the same price at every dose, covering the clinician review, medication, shipping and support. It says it serves all 50 states and offers a conditional money-back guarantee.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Coivas
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Coivas at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $249/mo
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Coivas
Each dimension is scored algorithmically from Coivas’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.8/10At $249/mo, Coivas runs about 35% above the $185 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.3/10Coivas offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.6/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
9.0/10Key details fully confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy.
Accessibility10%
8.5/10Coivas treats patients in all 50 states.
Support10%
6.1/10Coivas provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Coivas review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $249–$299/mo across 2 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Coivas
We walked Coivas’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Pick semaglutide or tirzepatide on the treatment page and toggle between the quarterly and monthly price.
- 2Tap See if you qualify or Get started to open Coivas' online intake.
- 3The first intake screen asks for your height, weight, goal weight, shipping state, date of birth and health history.
- Treatment pages show the full price before intake: semaglutide $249/mo monthly or $178/mo quarterly; tirzepatide $299/mo monthly or $254/mo quarterly.
- The homepage advertises 'from $119/mo' and 'from $199/mo' with a promo banner, which doesn't match the plan prices on the treatment pages.
- Prices are listed as the same at every dose, with no membership or per-visit fees.
- The Challenge page promises a 3-month money-back trial, while the Terms require 6 months of continuous enrollment.
- Cancellation is self-serve in the patient portal; shipped medication can't be returned.
Coivas customer support
- support@coivas.com
GLP-1 medications Coivas offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$249 billed monthly; same price at every dose; includes clinician review, medication, shipping and support. Longer plan: quarterly $178/mo ($534 every 3 months).
$299 billed monthly; same price at every dose; includes clinician review, medication, shipping and support. Longer plan: quarterly $254/mo ($762 every 3 months).
Ready to get started?
Plans and promotions change often, so check Coivas's current pricing and active discounts before you decide.
What we like
- One price covers the clinician review, medication, shipping and support, with no membership fee
- Same price at every dose, so your cost doesn't climb as your dose goes up
- Quarterly plan lowers the cost to $178/mo for semaglutide and $254/mo for tirzepatide
- LegitScript seal on the site, and it names its clinical provider network (Beluga Health)
- Available in all 50 states; HSA/FSA eligible; cancel anytime from the patient portal
Watch-outs
- Month-to-month pricing is high: $249/mo for semaglutide and $299/mo for tirzepatide
- The lowest rates need a quarterly plan billed $534 or $762 every 3 months
- Homepage 'from $119/mo' and 'from $199/mo' figures don't match the plan prices on its own treatment pages
- Money-back guarantee needs 6 months of continuous enrollment with strict conditions, though the Challenge page says 3 months
- Dispensing pharmacies are described only by type (503A/503B), not named
- Compounded injectables only, no brand-name options; binding arbitration in New York
Is Coivas worth it?
Coivas built its program around one core idea: all-inclusive compounded GLP-1 at one flat price per dose, with a conditional money-back guarantee. It runs $249/month at every dose, a premium versus the rest of the category, so its specific extras need to earn the difference. Its flat, all-dose pricing helps anyone worried about cost climbing as they titrate up.
Coivas charges the same price at every dose. It also refunds you if it doesn't work out and is LegitScript-certified.
How much Coivas costs
Compounded semaglutide runs $249/month and compounded tirzepatide runs $299/month.
For context, the median across the GLP-1 providers we track (each program's lowest listed ongoing monthly price for compounded semaglutide) is around $185/month. Coivas's standing rate sits at the premium end of that range, well above the cheapest options in the category.
For a direct comparison, Wellorithm runs semaglutide and tirzepatide from $247/month, so compare it with Coivas before you commit.
Medications: what Coivas prescribes
Coivas prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.
Who Coivas is best for, and who should skip it
A good fit if you…
- live anywhere in the US and want the certainty that your state is already covered.
Look elsewhere if you…
- want the lowest total cost over 6–12 months, where a flat-rate provider like altRX will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
Coivas treats patients in all 50 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Coivas costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, PlexusDx is one of the closest alternatives we track; compare the two before deciding.
The Bottom Line
Coivas scores highest on trust and safety in our breakdown.
Ready to start with Coivas?
From $249/mo. See current pricing and start your free consultation.
Coivas might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Coivas vs…
Coivas scores7.7/10
Side-by-side pricing, medications and scores. Pick a matchup.
Coivas vs Amazon One Medical
Amazon One Medical scores 8.5/10

Coivas vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Coivas review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Coivas's current pricing
Plans from $249/mo. Start your free consultation to check eligibility and today's price.